Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Odyssey Health, Inc.
CIK: 1626644
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2015-12-01
Last Filing Date: 2025-03-14
SEC Filings
Start End Frame Filed ACCN Value View
2021-08-01 2021-10-31 CY2021Q3 2021-12-10 0001683168-21-006265 $ 88,064,376 View
2014-08-01 2015-07-31 CY2014Q2 2015-12-01 0001019687-15-004380 $ 114,750,000 View
2015-08-01 2015-10-31 CY2014Q3 2015-12-22 0001019687-15-004599 $ 114,750,000 View
2015-11-01 2016-01-31 CY2014Q4 2016-03-15 0001019687-16-005466 $ 114,750,000 View
2016-02-01 2016-04-30 CY2015Q1 2016-06-16 0001019687-16-006697 $ 114,750,000 View
2019-11-01 2020-01-31 CY2019Q4I 2020-03-12 0001683168-20-000778 $ 87,123,009 View
2019-11-01 2020-01-31 CY2019Q4 2020-11-13 0001683168-20-003886 $ 87,123,009 View
2020-02-01 2020-04-30 CY2020Q1I 2020-06-04 0001683168-20-001856 $ 87,170,622 View
2020-02-01 2020-04-30 CY2020Q1 2020-11-13 0001683168-20-003888 $ 87,170,622 View
2019-08-01 2020-07-31 CY2019 2020-11-16 0001683168-20-003913 $ 87,123,187 View
2023-08-01 2023-10-31 CY2023Q3 2023-12-15 0001683168-23-008887 $ 65 View
2020-08-01 2020-10-31 CY2019Q3 2020-12-11 0001683168-20-004260 $ 90,281,255 View
2020-11-01 2021-01-31 CY2019Q4 2021-03-11 0001683168-21-000891 $ 90,913,898 View
2021-02-01 2021-04-30 CY2021Q1 2021-06-21 0001683168-21-002648 $ 98,382,540 View
2015-08-01 2016-07-31 CY2015 2016-11-02 0001683168-16-000458 $ 114,750,000 View
2016-08-01 2016-10-31 CY2015Q3 2016-12-20 0001683168-16-001000 $ 114,750,000 View
2016-11-01 2017-01-31 CY2015Q4 2017-03-23 0001683168-17-000643 $ 114,840,574 View
2017-02-01 2017-04-30 CY2016Q1 2017-06-21 0001683168-17-001641 $ 114,839,600 View
2016-08-01 2017-07-31 CY2016 2017-11-14 0001683168-17-003008 $ 114,794,677 View
2017-08-01 2017-10-31 CY2016Q3 2017-12-20 0001683168-17-003357 $ 114,839,600 View
2017-11-01 2018-01-31 CY2016Q4 2018-05-30 0001683168-18-001563 $ 116,361,339 View
2018-02-01 2018-04-30 CY2017Q1 2018-08-07 0001683168-18-002153 $ 119,839,600 View
2017-08-01 2018-07-31 CY2017 2018-12-12 0001683168-18-003679 $ 117,128,060 View
2018-08-01 2018-10-31 CY2017Q3 2019-03-13 0001683168-19-000633 $ 61,414,000 View
2018-11-01 2019-01-31 CY2017Q4 2019-03-14 0001683168-19-000655 $ 64,703,372 View
2019-02-01 2019-04-30 CY2018Q1 2019-06-07 0001683168-19-001828 $ 68,660,007 View
2018-08-01 2019-07-31 CY2019Q2I 2019-10-23 0001683168-19-003350 $ 69,898,436 View
2018-08-01 2019-07-31 CY2018 2020-11-13 0001683168-20-003882 $ 69,898,436 View
2019-08-01 2019-10-31 CY2019Q3I 2019-12-06 0001683168-19-003899 $ 86,990,400 View
2019-08-01 2019-10-31 CY2019Q3 2020-11-13 0001683168-20-003884 $ 86,990,400 View
2020-08-01 2021-07-31 CY2020 2021-10-29 0001683168-21-005136 $ 93,734,074 View
2021-08-01 2022-01-31 CY2021Q4I 2022-03-15 0001683168-22-001689 $ 0 View
2022-02-01 2022-04-30 CY2021Q1 2022-06-14 0001683168-22-004342 $ 83,948,500 View
2022-11-01 2023-01-31 CY2021Q4 2023-03-17 0001683168-23-001588 $ 592 View
2022-03-01 2022-03-03 CY2022Q1I 2022-10-31 0001683168-22-007161 $ 374,085 View
2022-08-01 2022-10-31 CY2022Q3 2022-12-14 0001683168-22-008426 $ 474 View
2023-02-01 2023-04-30 CY2023Q1 2023-06-14 0001683168-23-004137 $ -79 View
2022-10-01 2022-10-31 CY2022Q3I 2023-10-30 0001683168-23-007508 $ 8,800 View
2023-11-01 2024-01-31 CY2023Q4 2024-03-22 0001683168-24-001645 $ 0 View
2023-04-01 2024-04-30 CY2023 2024-06-14 0001683168-24-004251 $ 7,775,000 View
2023-08-01 2024-07-31 CY2024 2024-11-13 0001683168-24-007967 $ 0 View
2024-08-01 2024-10-31 CY2024Q3 2024-12-16 0001683168-24-008756 $ -370,698 View
2024-08-01 2025-01-31 CY2024Q4I 2025-03-14 0001683168-25-001617 $ -370,698 View
SEC Facts By Type
Type Name Description View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Long-term Debt, Excluding Current Maturities Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Prepaid Expense and Other Assets, Noncurrent Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer. View
us-gaap Research and Development Expense (Excluding Acquired in Process Cost) The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. View
us-gaap Estimated Litigation Liability Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Accrued Salaries, Current Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Deposits Assets, Current Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Amortization The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. View
us-gaap Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. View
us-gaap Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Accounts Receivable, Allowance for Credit Loss Amount of allowance for credit loss on accounts receivable. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Asset Impairment Charges Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets Sold under Agreements to Repurchase, Repurchase Liability Amount to be repaid to the counterparty to the repurchase agreement when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under the repurchase agreement exceeds 10 percent of total assets. View
us-gaap Business Combination, Contingent Consideration, Liability, Current Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash, Period Increase (Decrease) Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes. View
us-gaap Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Cost of Goods Sold (Deprecated 2018-01-31) Total costs related to goods produced and sold during the reporting period. View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Long-term Debt, Gross Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. View
us-gaap Debt Instrument, Convertible, Beneficial Conversion Feature Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. View
us-gaap Debt Instrument, Convertible, Conversion Price The price per share of the conversion feature embedded in the debt instrument. View
us-gaap Debt Instrument, Fair Value Disclosure Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable. View
us-gaap Debt Instrument, Interest Rate, Stated Percentage Contractual interest rate for funds borrowed, under the debt agreement. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Debt Instrument, Unamortized Discount, Current Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer. View
us-gaap Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Due to Officers or Stockholders, Current Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Employee-related Liabilities Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, after Year Five Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Year One Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year. View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Year Five Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Year Four Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Year Three Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Asset, Expected Amortization, Year Two Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Finite-Lived Intangible Assets, Gross Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Other than Temporary Impairment Losses, Investments The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Accrued Salaries The increase (decrease) during the period in accrued salaries. View
us-gaap Increase (Decrease) in Deposit Assets The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits. View
us-gaap Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. View
us-gaap Increase (Decrease) in Notes Payable, Current The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes. View
us-gaap Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Amount of investment in equity method investee and investment in and advance to affiliate. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Long-term Debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Notes and Loans Payable, Current Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer. View
us-gaap Financing Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable. View
us-gaap Notes Issued The fair value of notes issued in noncash investing and financing activities. View
us-gaap Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Assets Amount of assets classified as other. View
us-gaap Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. View
us-gaap Other Noninterest Expense Amount of noninterest expense classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Payments of Financing Costs The cash outflow for loan and debt issuance costs. View
us-gaap Payments to Acquire Businesses and Interest in Affiliates The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment). View
us-gaap Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. View
us-gaap Payments to Acquire Interest in Subsidiaries and Affiliates The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity). View
us-gaap Payments to Acquire Investments The cash outflow associated with the purchase of all investments (debt, security, other) during the period. View
us-gaap Payments to Acquire Notes Receivable The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Bank Debt The cash inflow from bank borrowing during the year. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Research and Development in Process The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Value, Purchase of Assets Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, Forfeited Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Accounts Payable, Related Parties Amount for accounts payable to related parties. View
us-gaap Accrued Salaries Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Debt Instrument, Interest Rate During Period The average effective interest rate during the reporting period. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Other Research and Development Expense Amount of other research and development expense. View
us-gaap Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Amount of unamortized debt discount (premium) and debt issuance costs. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Loans Payable Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). View
us-gaap Other Income Amount of revenue and income classified as other. View
us-gaap Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Common Unit, Issued Number of common units issued of limited liability company (LLC). View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Research and Development Expense, Software (Excluding Acquired in Process Cost) Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt, Current Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Interest Expense, Other Amount of interest expense classified as other. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Other Expenses Amount of expense classified as other. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Sales Commissions and Fees Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). View
us-gaap Other Nonoperating Expense Amount of expense related to nonoperating activities, classified as other. View
us-gaap Other Operating Income (Expense), Net The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. View
us-gaap Employee Benefits and Share-based Compensation Amount of expense for employee benefit and equity-based compensation. View
us-gaap Stock Repurchased and Retired During Period, Shares Number of shares that have been repurchased and retired during the period. View
us-gaap Stock Repurchased and Retired During Period, Value Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). View
us-gaap Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Convertible Preferred Dividends, Net of Tax The after-tax amount of any dividends on convertible preferred stock. View
us-gaap Dividends Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock. View
us-gaap Gain (Loss) on Disposition of Assets Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. View
us-gaap Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. View
us-gaap Interest on Convertible Debt, Net of Tax The after-tax amount of interest recognized in the period associated with any convertible debt. View
us-gaap Investments Sum of the carrying amounts as of the balance sheet date of all investments. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Net Income (Loss) Available to Common Stockholders, Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. View
us-gaap Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other. View
us-gaap Proceeds from Sale of Productive Assets The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. View
us-gaap Loss on Sale of Investments The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale. View
us-gaap Repayments of Other Short-term Debt Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Dividends, Common Stock Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). View
us-gaap Increase (Decrease) in Other Receivables Amount of increase (decrease) in receivables classified as other. View
us-gaap 2634030 None View
us-gaap Other Receivables, Net, Current Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Unrealized Gain (Loss) on Investments Amount of unrealized gain (loss) on investment. View
Chart of Accounts => Accounts
Name View
Deferred Tax Assets, Net of Valuation Allowance View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Payments to Acquire Businesses and Interest in Affiliates View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Payments of Financing Costs View
Deferred Tax Assets, Gross View
Other Noninterest Expense View
Other Nonoperating Income View
Accounts Payable, Current View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accrued Salaries, Current View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Amortization View
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature View
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Warrant Issued View
Share-based Payment Arrangement, Expense View
Accounts Receivable, Allowance for Credit Loss View
Amortization of Debt Discount (Premium) View
Amortization of Intangible Assets View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Asset Impairment Charges View
Assets View
Assets, Current View
Assets Sold under Agreements to Repurchase, Repurchase Liability View
Business Combination, Contingent Consideration, Liability, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Cash, Period Increase (Decrease) View
Commitments and Contingencies View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Convertible Notes Payable View
Cost of Goods Sold (Deprecated 2018-01-31) View
Cost of Revenue View
Long-term Debt, Gross View
Debt Instrument, Convertible, Beneficial Conversion Feature View
Debt Instrument, Convertible, Conversion Price View
Debt Instrument, Fair Value Disclosure View
Debt Instrument, Interest Rate, Stated Percentage View
Debt Instrument, Unamortized Discount View
Debt Instrument, Unamortized Discount, Current View
Deferred Income Tax Expense (Benefit) View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Valuation Allowance View
Deposits Assets, Current View
Depreciation View
Depreciation, Depletion and Amortization, Nonproduction View
Due to Officers or Stockholders, Current View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Employee-related Liabilities View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Finite-Lived Intangible Assets, Accumulated Amortization View
Finite-Lived Intangible Asset, Expected Amortization, after Year Five View
Finite-Lived Intangible Asset, Expected Amortization, Year One View
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year View
Finite-Lived Intangible Asset, Expected Amortization, Year Five View
Finite-Lived Intangible Asset, Expected Amortization, Year Four View
Finite-Lived Intangible Asset, Expected Amortization, Year Three View
Finite-Lived Intangible Asset, Expected Amortization, Year Two View
Finite-Lived Intangible Assets, Gross View
Finite-Lived Intangible Assets, Net View
Gain (Loss) on Extinguishment of Debt View
General and Administrative Expense View
Gross Profit View
Other than Temporary Impairment Losses, Investments View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Accrued Salaries View
Increase (Decrease) in Deposit Assets View
Increase (Decrease) in Interest Payable, Net View
Increase (Decrease) in Notes Payable, Current View
Increase (Decrease) in Other Current Assets View
Increase (Decrease) in Prepaid Expense View
Intangible Assets, Net (Excluding Goodwill) View
Interest Expense View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Interest Payable, Current View
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures View
Issuance of Stock and Warrants for Services or Claims View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Long-term Debt View
Long-term Debt, Excluding Current Maturities View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Notes and Loans Payable, Current View
Financing Receivable, after Allowance for Credit Loss, Current View
Notes Issued View
Notes Payable View
Notes Payable, Current View
Operating Income (Loss) View
Operating Loss Carryforwards View
Other Assets View
Other Noncash Income (Expense) View
Payments to Acquire Intangible Assets View
Payments to Acquire Interest in Subsidiaries and Affiliates View
Payments to Acquire Investments View
Payments to Acquire Notes Receivable View
Payments to Acquire Property, Plant, and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Issued View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Bank Debt View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance or Sale of Equity View
Proceeds from Notes Payable View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Net View
Repayments of Notes Payable View
Research and Development Expense View
Research and Development in Process View
Retained Earnings (Accumulated Deficit) View
Revenues View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Stockholders' Equity Attributable to Parent View
Stock Issued View
Stock Issued During Period, Shares, Acquisitions View
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Stock Issued During Period, Value, Purchase of Assets View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Shares Issued, Value, Share-based Payment Arrangement, Forfeited View
Unrecognized Tax Benefits View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Accounts Payable, Related Parties View
Accrued Salaries View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Debt Instrument, Interest Rate During Period View
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months View
Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five View
Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five View
Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four View
Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three View
Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two View
Loans Payable View
Other Income View
Proceeds from Issuance of Debt View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Common Unit, Issued View
Earnings Per Share, Diluted View
Proceeds from Issuance of Private Placement View
Research and Development Expense, Software (Excluding Acquired in Process Cost) View
Sale of Stock, Price Per Share View
Shares, Issued View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Value, Acquisitions View
Stock Repurchased During Period, Value View
Weighted Average Number of Shares Outstanding, Diluted View
Accrued Liabilities, Current View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Conversion of Stock, Shares Converted View
Debt, Current View
Debt Instrument, Face Amount View
Interest Expense, Other View
Notes Payable, Related Parties, Current View
Other Expenses View
Other Research and Development Expense View
Prepaid Expense and Other Assets, Noncurrent View
Proceeds from Issuance of Warrants View
Sales Commissions and Fees View
Other Nonoperating Expense View
Other Operating Income (Expense), Net View
Employee Benefits and Share-based Compensation View
Stock Repurchased and Retired During Period, Shares View
Stock Repurchased and Retired During Period, Value View
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property View
Other Nonoperating Income (Expense) View
Convertible Preferred Dividends, Net of Tax View
Dividends View
Gain (Loss) on Disposition of Assets View
Gain (Loss) on Investments View
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants View
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities View
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements View
Interest on Convertible Debt, Net of Tax View
Investments View
Net Income (Loss) Available to Common Stockholders, Basic View
Net Income (Loss) Available to Common Stockholders, Diluted View
Proceeds from (Payments for) Other Financing Activities View
Proceeds from Sale of Productive Assets View
Research and Development Expense (Excluding Acquired in Process Cost) View
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net View
Estimated Litigation Liability View
Loss on Sale of Investments View
Repayments of Other Short-term Debt View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Dividends, Common Stock View
Increase (Decrease) in Other Receivables View
2610999 View
Other Receivables, Net, Current View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Unrealized Gain (Loss) on Investments View